S. Muoio & Co’s Achillion Pharmaceuticals ACHN Stock Holding History

S. Muoio & Co’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-139,907	Closed	-$844K	–	79
2019 Q4	$844K	Buy	+139,907	New	+$810K	0.76%	40

S. Muoio & Co's ACHN Position: Q1 2020 in Review

S. Muoio & Co sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 139,907 shares — an estimated $844K sold.

S. Muoio & Co first reported a position in ACHN in Q4 2019 and held it in 1 quarter. The position peaked at $844K in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

S. Muoio & Co reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
S. Muoio & Co sold 139,907 Achillion Pharmaceuticals shares in Q1 2020, an estimated $844K.
S. Muoio & Co first reported a position in Achillion Pharmaceuticals in Q4 2019 and held it in 1 quarter.
S. Muoio & Co's Achillion Pharmaceuticals position peaked at $844K in Q4 2019.
0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on S. Muoio & Co's 13F filing for Q1 2020, filed 14 May 2020.